XML 86 R71.htm IDEA: XBRL DOCUMENT v3.25.0.1
GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Mar. 31, 2022
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2020
Intangible Assets [Line Items]                
Accumulated goodwill impairment losses         $ 0      
Aggregate amortization expense related to finite-lived intangible assets         $ 2,400 $ 2,300 $ 1,800  
Discount rate of acquired IPR&D     7.50%   7.25% 7.50% 7.50%  
In-process research and development impairments         $ 4,180 $ 50 $ 2,700  
Fair Value, Nonrecurring | Galapagos                
Intangible Assets [Line Items]                
Aggregate amortization expense related to finite-lived intangible assets           $ 51    
In Process Research And Development NSCLC                
Intangible Assets [Line Items]                
In-process research and development impairments $ 1,800 $ 2,400            
In Process Research And Development Bulevirtide | Fair Value, Nonrecurring                
Intangible Assets [Line Items]                
In-process research and development impairments     $ 50          
In Process Research And Development Trodelvy For HR+/HER2-                
Intangible Assets [Line Items]                
Indefinite-lived intangible assets, fair value       $ 6,100        
In Process Research And Development Trodelvy For HR+/HER2- | Fair Value, Nonrecurring                
Intangible Assets [Line Items]                
In-process research and development impairments       $ 2,700        
Immunomedics, Inc. | In Process Research And Development NSCLC | Measurement Input, Discount Rate                
Intangible Assets [Line Items]                
Discount rate, measurement input 7.00% 7.00%            
Immunomedics, Inc. | In Process Research And Development Trodelvy For HR+/HER2-                
Intangible Assets [Line Items]                
Aggregate fair value of acquired IPR&D               $ 8,800
Immunomedics, Inc. | In Process Research And Development Trodelvy For HR+/HER2- | Measurement Input, Discount Rate                
Intangible Assets [Line Items]                
Discount rate, measurement input       6.75%